ORAMED PHARMACEUTICALS INC (ORMP) Stock Price, Quote, News and Overview
NASDAQ:ORMP - Nasdaq - US68403P2039 - Common Stock - Currency: USD
ORMP Quote, Performance and Key Statistics
ORAMED PHARMACEUTICALS INC
NASDAQ:ORMP (1/29/2025, 8:00:02 PM)
2.25
0 (0%)
The current stock price of ORMP is 2.25 USD. In the past month the price decreased by -5.06%. In the past year, price decreased by -18.18%.
ORMP Latest News, Press Releases and Analysis
Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ("Oramed"), a clinical-stage pharmaceutical company focused on the development of oral...
ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q2 2024
ORMP stock results show that Oramed Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024.
ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Oramed Pharmaceuticals (NASDAQ:ORMP) just reported results for the second quart...
3 Micro-Cap Moonshots for Fearless Investors
Investors should know the risks of micro-cap stocks before looking into these three high-potential companies with low prices.
Oramed Letter to Shareholders
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ("Oramed") (www.oramed.com), a clinical-stage pharmaceutical company focused on the...
Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (the "Company") (www.oramed.com), a clinical-stage pharmaceutical company focused on...
ORMP Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 79.06 | 763.33B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 28.29 | 373.21B | ||
| JNJ | JOHNSON & JOHNSON | 15.13 | 363.91B | ||
| MRK | MERCK & CO. INC. | 16.52 | 248.61B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.44 | 217.85B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.8 | 205.78B | ||
| PFE | PFIZER INC | 10.32 | 150.86B | ||
| SNY | SANOFI-ADR | 12.48 | 130.75B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 50.47 | 119.76B | ||
| ZTS | ZOETIS INC | 29.55 | 76.80B | ||
| GSK | GSK PLC-SPON ADR | 8.47 | 71.53B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 22.18 | 42.20B |
Related stock screener links
About ORMP
Company Profile
Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. The company is headquartered in New York City, New York and currently employs 15 full-time employees. The company went IPO on 2002-04-01. The firm has developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its Protein Oral Delivery (POD) technology is designed to protect drug integrity and increase absorption. Its pipeline includes ORMD-0801 (Oral Insulin) Diabetes, ORMD-0801 (Oral Insulin) NASH, and ORMD 0901 (Oral GLP-1). Its oral insulin (ORMD-0801) has the potential to create a new paradigm in the treatment of diabetes through oral delivery of insulin at an earlier stage of treatment. Its oral insulin capsule (ORMD-0801) has shown a reduction of liver fat content in early clinical trials. The company is also developing an oral Glucagon-like peptide-1 (GLP-1) analog capsule (ORMD-0901), which is an incretin hormone that stimulates the secretion of insulin from the pancreas.
Company Info
ORAMED PHARMACEUTICALS INC
1185 Avenue Of The Americas, 3Rd Floor
New York City NEW YORK 10036 US
CEO: Nadav Kidron
Employees: 15
Company Website: https://oramed.com/
Investor Relations: https://oramed.com/investor-relations/
Phone: 16468441164
ORMP FAQ
What is the stock price of ORMP?
The current stock price of ORMP is 2.25 USD.
What is the symbol for ORAMED PHARMACEUTICALS INC stock?
The exchange symbol of ORAMED PHARMACEUTICALS INC is ORMP and it is listed on the Nasdaq exchange.
On which exchange is ORMP stock listed?
ORMP stock is listed on the Nasdaq exchange.
Is ORMP a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for ORMP, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of ORMP.
Does ORMP stock pay dividends?
ORMP does not pay a dividend.
What is the Price/Earnings (PE) ratio of ORMP?
The PE ratio for ORMP is 15. This is based on the reported non-GAAP earnings per share of 0.15 and the current share price of 2.25 USD.
What is the Short Interest ratio of ORMP stock?
The outstanding short interest for ORMP is 0.68% of its float.
ORMP Technical Analysis
ORMP Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ORMP. While ORMP has a great health rating, there are worries on its profitability.
ORMP Financial Highlights
Over the last trailing twelve months ORMP reported a non-GAAP Earnings per Share(EPS) of 0.15. The EPS decreased by 136.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | 2.7% | ||
| ROE | 2.85% | ||
| Debt/Equity | 0 |
ORMP Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 46% to ORMP. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of -125.5% and a revenue growth -100% for ORMP